Skip to main content
Olema Oncology

Senior Medical Science Liaison (Southeast Region)

RemoteUnited States only· UTC-8…UTC-5
Published
Role
Research
Experience
Senior
Employment
Full-time
Company size
Startup
$185k–$200k/yr
Check eligibility

Open to US only · UTC-8…UTC-5. Set where you work from to check your eligibility.

No BS summary

Senior Medical Science Liaison with a Doctorate degree (MD, PharmD, or PhD) and 5+ years of medical affairs or field medical experience in oncology, specifically solid tumors and preferably breast cancer. Must have strong analytical, communication, and presentation skills, with experience in clinical trial development and drug launches. Field experience in the Southeast region is strongly preferred. Requires ability to simplify complex information, build relationships, manage projects, and work cross-functionally.

Core skills

medical science liaisononcologybreast cancer

Required skills

Oncology therapeutic expertiseanalytical skillscommunication skillspresentation skillsclinical trial developmentdrug launch

Optional skills

breast cancer experiencefield medical experience within the Southeast region

What you'll do

  • Serve as a scientific expert and external representative for Olema.
  • Engage with key opinion leaders and healthcare providers to facilitate scientific exchange, communicate medical and clinical information, and support Olema's medical affairs objectives.
  • Identify, connect, cultivate and maintain relationships with key opinion leaders, healthcare professionals and researchers in both academic and community centers within the assigned territory.
  • Develop and execute territory engagement plans that aligned with medical affairs strategies to optimize impact in the field.
  • Provide medical and scientific insights to internal stakeholders to inform product development and strategy.
  • Facilitate and support new and ongoing clinical research in collaboration with medical and clinical operations teams (company-sponsored trials, investigator-initiated studies, and other collaborative initiatives).
  • Serve as a trusted scientific and medical resource, providing accurate and updated information about Olema therapies and research externally.
  • Conduct medical education programs and presentations to healthcare professionals as needed to relay information about Olema’s products and research.
  • Maintain up-to-date knowledge of developments in breast cancer research, treatment options, and disease management.
  • Professionally represent Olema at select medical and scientific conferences and meetings.
  • Serve as scientific resource to commercial partners, as appropriate, to support activities.

What they require

  • Doctorate degree (MD, PharmD or PhD)
  • Oncology therapeutic expertise required
  • Strong analytical skills demonstrating the ability to identify and understand complex issues/problems
  • Strong communication and presentation skills required
  • Minimum of 5 years of medical affairs or field medical experience with a verifiable record of high performance
  • Prior experience in solid tumors required with breast cancer experience strongly preferred
  • Clinical trial development and drug launch experience strongly preferred
  • Field medical experience within the Southeast region strongly preferred
  • Simplifying complex information into clear, concise messages to effectively communicate the company story
  • Excellent communication skills – written, verbal, presentation, interpersonal
  • Serving in a high-visibility role and making public presentations to a variety of audiences
  • Ability to work in cross-functional teams with internal stakeholders
  • Anticipating needs, meeting tight deadlines, being proactive, and exercising independent decision-making
  • Managing the communication of sensitive and confidential information
  • This is a role where judgement, tact, flexibility and resourcefulness are key
  • Strong relationship-building and negotiating skills
  • Highly organized with an attention to detail and ability to meet timelines in a fast-paced environment
  • Strong project management skills; can work on multiple projects simultaneously and effectively prioritize workload

Benefits

  • competitive compensation and benefits package
  • open, flexible, and friendly work environment
  • platform to develop their long-term careers
  • A Summary of Benefits is available for all applicants.

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema , with our transfor mation into a fully integrated oncology company well underway , t op-line data from our lead program expected later this year , and our first potential commercial launch on the horizon. Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC. Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day. If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond .

BiopharmaceuticalsStartup
$185k–$200k/yr